Named one of FastCompany's Most Innovative Companies in 2017 and Crain's Biotechs to Watch,​ Celmatix is changing the face of women's health through the development of digital tools and genetic insights focused on fertility potential. Our unique approach combines data science and genomics to bring personalized medicine to fertility. Our leadership team includes a diverse group of world-class scientists and professionals, including our Founder and CEO Dr. Piraye Yurttas Beim, who was recently recognized by Fortune Magazine as one of 15 Entrepreneurs Disrupting their Industries, Inc Magazine's 10 Women to Watch in Tech, an Aspen Institute Health Innovator Fellow, and an NYC Venture Fellow by the NYCEDC. Learn more about Celmatix at www.celmatix.com